RBI
ARCT icon

Raiffeisen Bank International’s Arcturus Therapeutics ARCT Stock Holding History

Raiffeisen Bank International’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.88K Hold
1,321
– – ﹤0.01% 721
2026
Q1 		$10.2K Hold
1,321
– – ﹤0.01% 740
2025
Q4 		$6.88K Hold
1,321
– – ﹤0.01% 750
2025
Q3 		$24.3K Buy
+1,321
New +$21.2K ﹤0.01% 601

Other funds holding ARCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Raiffeisen Bank International's ARCT Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 1,321 shares — an estimated $21.2K sold.

Raiffeisen Bank International first reported a position in ARCT in Q4 2024 and held it in 3 quarters. The position peaked at $22.2K in Q4 2024. 136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 1,321 Arcturus Therapeutics shares in Q3 2025, an estimated $21.2K.
  • Raiffeisen Bank International first reported a position in Arcturus Therapeutics in Q4 2024 and held it in 3 quarters.
  • Raiffeisen Bank International's Arcturus Therapeutics position peaked at $22.2K in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.